Frédéric Antonio Carvalho Selected Research

Interleukin-22 (IL-22)

1/2022

AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frédéric Antonio Carvalho Research Topics

Disease

4	Inflammation (Inflammations) 09/2023 - 01/2018
3	Hypersensitivity (Allergy) 09/2023 - 01/2019
2	Visceral Pain 09/2023 - 01/2019
2	Pain (Aches) 01/2023 - 01/2019
2	Infections 01/2022 - 01/2020
1	Cognitive Dysfunction 01/2022
1	Post-Infectious Disorders 01/2022
1	Gastroenteritis 01/2022
1	Chronic Pain 01/2020
1	Cystitis 01/2019
1	Hyperalgesia 01/2019
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2019
1	Cysts 01/2018
1	Persistent Infection 01/2018
1	Crohn Disease (Crohn's Disease) 03/2007
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2007

Drug/Important Bio-Agent (IBA)

2	Volatile Fatty AcidsIBA 01/2022 - 01/2020
2	CytokinesIBA 01/2022 - 01/2019
2	LigandsIBA 01/2020 - 01/2019
1	Dextran SulfateIBA 09/2023
1	4- chloro- 2- fluoro- N- (2- fluorophenyl)- 5- (hexahydropyrrolo(1,2- a)pyrazin- 2(1H)- ylcarbonyl)benzenesulfonamideIBA 01/2023
1	tryptopholIBA 01/2022
1	indoleIBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	CalciumIBA 01/2019
1	Prostaglandins BIBA 01/2019
1	Pregabalin (Lyrica)FDA Link 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Purinergic P2X ReceptorsIBA 01/2018
1	AntibodiesIBA 03/2007

Therapy/Procedure

2	Oral Administration 09/2023 - 01/2018
1	Complementary Therapies (Alternative Medicine) 09/2023
1	Intraperitoneal Injections 01/2019
1	Therapeutics 01/2019